$1.16-0.05|(-4.13%)
52W H: 2.7252W L: 0.5632Beta: 1.68

About Inovio Pharmaceuticals Inc

Frequently Asked Questions

What is the 52-week range for INO?

The 52-week high is $2.72 and the 52-week low is $0.5632.

What is the P/E ratio for INO?

The P/E ratio data is currently unavailable.

What is the dividend yield for INO?

This company does not currently pay a dividend or the data is unavailable.

What is the Return on Equity (ROE)?

The trailing twelve months (TTM) Return on Equity is -190.50%.

What is the Net Profit Margin?

The Net Profit Margin (TTM) is -25107.34%.

What is the Price to Book (P/B) Ratio?

The annual Price to Book ratio stands at 4.96.

Analyst Recommendation Trends

Wall Street analyst consensus for INO over the last few months:

2026-09-01
Buy: 4
S.Buy: 2
Hold: 2
Sell: 0
2026-08-01
Buy: 4
S.Buy: 1
Hold: 3
Sell: 0
2026-07-01
Buy: 4
S.Buy: 2
Hold: 3
Sell: 0
2026-06-01
Buy: 4
S.Buy: 3
Hold: 3
Sell: 0

Latest INO News

PGEN vs. IRWD: Which Biotech Stock Offers Better Growth Potential?

Precigen's Papzimeos and Ironwood's Linzess are driving growth, but competition, pipeline progress and single-product reliance shape each biotech's outlook.

Yahoo9/30/2026

Can PGEN's AdenoVerse Pipeline Create Growth Beyond Papzimeos?

Precigen's Papzimeos is gaining commercial momentum, while its pipeline potential through the AdenoVerse platform could create new growth opportunities.

Yahoo9/24/2026

Precigen Gains 43% in 3 Months: Is It an Indication to Buy the Stock?

PGEN's Papzimeos is driving strong early sales, while European expansion and pipeline progress could shape the stock's growth outlook.

Yahoo9/14/2026

Inovio Nears FDA Decision on INO-3107 as Oct. 30 PDUFA Date Looms

Inovio Pharmaceuticals (NASDAQ:INO) said its biologics license application for INO-3107, an investigational DNA medicine for recurrent respiratory papillomatosis, or RRP, remains under U.S. Food and Drug Administration review, with a target action date of Oct. 30. President and CEO Jacqueline Shea

Yahoo9/11/2026

Inovio Pharmaceuticals, Inc. (INO) Presents at H.C. Wainwright 28th Annual Global Investment Conference Prepared Remarks Transcript

Inovio Pharmaceuticals, Inc. (INO) H.C.

SeekingAlpha9/11/2026

Can Papzimeos Drive Precigen's Growth Through the Rest of 2026?

Papzimeos is fueling Precigen's growth, with sales more than doubling sequentially in Q2 and demand continuing to rise in 2026.

Yahoo9/10/2026

Inovio Pharmaceuticals Nears Oct. 30 FDA Decision for INO-3107 in RRP

Inovio Pharmaceuticals (NASDAQ:INO) is approaching an October 30 PDUFA date for INO-3107, its lead DNA medicine candidate for recurrent respiratory papillomatosis, or RRP, President and CEO Jacky Shea said during a Cantor Fitzgerald fireside chat. Shea described Inovio as a clinical-stage company d

Yahoo9/10/2026

Inovio Pharmaceuticals, Inc. (INO) Presents at 12th Annual Cantor Fitzgerald Global Healthcare Conference Transcript

Inovio Pharmaceuticals, Inc. (INO) 12th Annual Cantor Fitzgerald Global Healthcare Conference September 9, 2026 3:20 PM EDTCompany ParticipantsJacqueline...

SeekingAlpha9/9/2026

Related Stocks (Peers)

Companies operating in similar sectors to INO:

Recent Insider Transactions

DateNameShares ChangedPriceValue
2026-05-20Sumner Michael John+37,684--
2026-05-20Sumner Michael John+46,876--
2026-05-20Sumner Michael John-9,450--
2026-05-20Sumner Michael John-2,693$1.23$3,312
2026-05-20Sumner Michael John+9,450--
2026-05-20Shea Jacqueline Elizabeth+100,240--
2026-05-20Shea Jacqueline Elizabeth+123,760--
2026-05-20Shea Jacqueline Elizabeth-28,296--
2026-05-20Shea Jacqueline Elizabeth-12,306$1.23$15,136
2026-05-20Shea Jacqueline Elizabeth+28,296--
2026-05-20Miller Ann Calby+34,200--
2026-05-20Miller Ann Calby+41,800--
2026-05-20Humeau Laurent+27,440--
2026-05-20Humeau Laurent+34,160--
2026-05-20Humeau Laurent-6,027--
2026-05-20Humeau Laurent-2,163$1.23$2,660
2026-05-20Humeau Laurent+6,027--
2026-05-20DANSEY ROGER D+34,200--
2026-05-20DANSEY ROGER D+41,800--
2026-05-20Weiner David B.+34,200--
2026-05-20Weiner David B.+41,800--
2026-05-20Shepard Jay+34,200--
2026-05-20Shepard Jay+41,800--
2026-05-20Zoth Lota S.+34,200--
2026-05-20Zoth Lota S.+41,800--
2026-05-20BENITO SIMON X+34,200--
2026-05-20BENITO SIMON X+41,800--
2026-05-20KIES PETER+32,480--
2026-05-20KIES PETER+39,760--
2026-05-20KIES PETER-8,700--
2026-05-20KIES PETER-4,688$1.23$5,766
2026-05-20KIES PETER+8,700--
2026-05-20YARNO WENDY L+34,200--
2026-05-20YARNO WENDY L+41,800--
2026-05-15Sumner Michael John-2,385--
2026-05-15Sumner Michael John-680$1.3$884
2026-05-15Sumner Michael John+2,385--
2026-05-15Shea Jacqueline Elizabeth-17,744--
2026-05-15Shea Jacqueline Elizabeth-7,717$1.3$10,032
2026-05-15Shea Jacqueline Elizabeth+17,744--
2026-05-15Humeau Laurent-4,771--
2026-05-15Humeau Laurent-1,712$1.3$2,226
2026-05-15Humeau Laurent+4,771--
2026-05-15KIES PETER-4,771--
2026-05-15KIES PETER-2,571$1.3$3,342
2026-05-15KIES PETER+4,771--
2026-03-31Sumner Michael John-4,292--
2026-03-31Sumner Michael John-1,223$1.74$2,128
2026-03-31Sumner Michael John+4,292--
2026-03-04Sumner Michael John+29,608--
2026-03-04Sumner Michael John+36,832--
2026-03-04Shea Jacqueline Elizabeth+78,760--
2026-03-04Shea Jacqueline Elizabeth+97,240--
2026-03-04Humeau Laurent+21,560--
2026-03-04Humeau Laurent+26,840--
2026-03-04KIES PETER+25,520--
2026-03-04KIES PETER+31,240--
2026-02-26Sumner Michael John-11,550--
2026-02-26Sumner Michael John-5,010--
2026-02-26Sumner Michael John-3,903$1.79$6,986
2026-02-26Sumner Michael John+11,550--
2026-02-26Sumner Michael John+5,010--
2026-02-26Shea Jacqueline Elizabeth-28,401--
2026-02-26Shea Jacqueline Elizabeth-18,632--
2026-02-26Shea Jacqueline Elizabeth-13,657$1.79$24,446
2026-02-26Shea Jacqueline Elizabeth+28,401--
2026-02-26Shea Jacqueline Elizabeth-8,057$1.79$14,422
2026-02-26Shea Jacqueline Elizabeth+18,632--
2026-02-26Humeau Laurent-7,366--
2026-02-26Humeau Laurent-5,010--
2026-02-26Humeau Laurent-3,034$1.79$5,431
2026-02-26Humeau Laurent+7,366--
2026-02-26Humeau Laurent-2,064$1.79$3,695
2026-02-26Humeau Laurent+5,010--
2026-02-26Weiner David B.-972--
2026-02-26Weiner David B.+972--
2026-02-26KIES PETER-10,634--
2026-02-26KIES PETER-5,010--
2026-02-26KIES PETER-6,294$1.79$11,266
2026-02-26KIES PETER+10,634--
2026-02-26KIES PETER-2,965$1.79$5,307
2026-02-26KIES PETER+5,010--